INS and Hypoglycemia: Wiedemann et al. showed that lupanine enhances glucose-stimulated insulin secretion in INS-1E cells and isolated mouse islets at elevated glucose levels (≥15 mmol/L), while having no effect under low-glucose conditions, indicating a glucose-dependent mechanism that minimizes hypoglycemia risk.